SynthesisCurrent oncology (Toronto, Ont.)2023

Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence.

Jie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.